{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:08:37Z","timestamp":1793725717222,"version":"4.6.1"},"update-to":[{"DOI":"10.1002\/14651858.cd006612.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000}}],"reference-count":239,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006612.pub5","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T09:17:07Z","timestamp":1502961427000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Homocysteine-lowering interventions for preventing cardiovascular events"],"prefix":"10.1002","volume":"2021","author":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud Eugenio Espejo; Universidad UTE (Cochrane Ecuador); Quito Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Sol\u00e0","sequence":"additional","affiliation":[{"name":"Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau); CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP); Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Lathyris","sequence":"additional","affiliation":[{"name":"\"George Gennimatas\" General Hospital; Thessaloniki Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Dayer","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Taunton and Somerset NHS Trust; Taunton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00223-015-9968-6","article-title":"Effect of vitamin B12 and folic acid supplementation on bone mineral density and quantitative ultrasound parameters in older people with an elevated plasma homocysteine level: B-PROOF, a randomized controlled trial","volume":"96","author":"Enneman","year":"2015","journal-title":"Calcified Tissue International"},{"issue":"9","key":"10.1002\/14651858.CD006612.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/HJH.0000000000000647","article-title":"Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial","volume":"33","author":"Dijk","year":"2015","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2318-11-80","article-title":"Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence","volume":"11","author":"Wijngaarden","year":"2011","journal-title":"BMC Geriatrics"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3945\/ajcn.114.090043","article-title":"Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial","volume":"100","author":"Wijngaarden","year":"2014","journal-title":"American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/STROKEAHA.108.526798","article-title":"High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial","volume":"40","author":"Hodis","year":"2009","journal-title":"Stroke"},{"issue":"Suppl II","key":"10.1002\/14651858.CD006612.pub5-BIB0006|cit6","first-page":"741","article-title":"Blinded comparison of folic acid and placebo in patients with ischaemic heart disease: an outcome trial","volume":"106","author":"Baker","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD006612.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0735-1097(17)35159-8","article-title":"Serum homocysteine lowering by long-term low-dose folic acid: new insight on MTHFR gene-folate interaction from China stroke primary prevention trial","volume":"69","author":"Huang","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"13","key":"10.1002\/14651858.CD006612.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jama.2015.2274","article-title":"Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial","volume":"313","author":"Huo","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2169\/internalmedicine.54.2931","article-title":"Effects of combined enalapril and folic acid therapy on the serum uric acid levels in hypertensive patients: a multicenter, randomized, double-blind, parallel-controlled clinical trial","volume":"54","author":"Li","year":"2015","journal-title":"Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/ijs.12017","article-title":"The China Stroke Secondary Prevention Trial (CSSPT) protocol: a double-blinded, randomized, controlled trial of combined folic acid and B vitamins for secondary prevention of stroke","volume":"10","author":"Liu","year":"2015","journal-title":"International Journal of Stroke"},{"issue":"11","key":"10.1002\/14651858.CD006612.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/STROKEAHA.116.014578","article-title":"Folic acid therapy reduces the first stroke risk associated with hypercholesterolemia among hypertensive patients","volume":"47","author":"Qin","year":"2016","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/ATVBAHA.116.308515","article-title":"Elevated homocysteine concentrations decrease the antihypertensive effect of angiotensin-converting enzyme inhibitors in hypertensive patients","volume":"37","author":"Qin","year":"2017","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ijc.30094","article-title":"Effect of folic acid supplementation on cancer risk among adults with hypertension in China: A randomized clinical trial","volume":"141","author":"Qin","year":"2017","journal-title":"International Journal of Cancer"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0014|cit14","unstructured":"Wang M Bie Z Guo L Wang J A 3-year clinical study reveals that enalapril folic acid tablet effectively controls H-type hypertension and improves ventricular structure and function Experimental and Clinical Cardiology 2014 20 6 3723 34"},{"issue":"8","key":"10.1002\/14651858.CD006612.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"e5862","DOI":"10.1097\/MD.0000000000005862","article-title":"Homocysteine and all-cause mortality in hypertensive adults without pre-existing cardiovascular conditions: Effect modification by MTHFR C677T polymorphism","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Xu B Kong X Xu R Zhao M Song Y Zhang C Impact of folic-acid intervention and MTHFRC677T gene polymorphism on all-cause mortality associated with elevated serum homocysteine levels in chinese adults with hypertension FASEB Journal 2016 30 1 Suppl 422.3","DOI":"10.1096\/fasebj.30.1_supplement.422.3"},{"issue":"10","key":"10.1002\/14651858.CD006612.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jamainternmed.2016.4687","article-title":"Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: the Renal Substudy of the China Stroke Primary Prevention Trial","volume":"176","author":"Xu","year":"2016","journal-title":"JAMA Internal Medicine"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2003.02.001","article-title":"Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial","volume":"93","author":"Liem","year":"2004","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0735-1097(03)00485-6","article-title":"Secondary prevention with folic acid: effects on clinical outcomes","volume":"41","author":"Liem","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/hrt.2004.035030","article-title":"Secondary prevention with folic acid: results of the Goes extension study","volume":"91","author":"Liem","year":"2005","journal-title":"Heart"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0828-282X(06)70238-0","article-title":"Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial","volume":"22","author":"Lonn","year":"2006","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1161\/STROKEAHA.108.529503","article-title":"Homocysteine lowering therapy and stroke risk, severity and disability: results from the HOPE-2 trial","volume":"40","author":"Saposnik","year":"2009","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Saposnik G Ray JG Sheridan P McQueen M Lonn E Heart Outcomes Prevention Evaluation Investigators Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial Stroke 2009 40 4 1365 72 19228852","DOI":"10.1161\/STROKEAHA.108.529503"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006612.pub5-BIB0025|cit25","first-page":"S334","article-title":"Prevention of cerebrovascular events by high-dose folic acid supplement in elderly female patients with hypertensive emergency and hyperhomocysteinemia","volume":"63","author":"Li","year":"2015","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.2010.840","article-title":"Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial","volume":"303","author":"Armitage","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0028|cit28","unstructured":"Clinical Trial Service Unit & Epidemiological Studies Unit SEARCH Study Protocol https:\/\/www.ctsu.ox.ac.uk\/research\/research-archive\/searchs\/search-study-protocol\/view 1 36"},{"issue":"9760","key":"10.1002\/14651858.CD006612.pub5-BIB0029|cit29","first-page":"126","article-title":"Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised","volume":"377","author":"Group Search Collaborative","year":"2011","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0030|cit30","doi-asserted-by":"crossref","unstructured":"Andreeva VA Latarche C Hercberg S Brian\u00e7on S Galan P Kesse-Guyot E B vitamin and\/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial PLOS One 2014 9 1 e84844","DOI":"10.1371\/journal.pone.0084844"},{"issue":"7","key":"10.1002\/14651858.CD006612.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archinternmed.2011.1450","article-title":"B vitamin and\/or \u03c9-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and\/or omega-3 fatty acids (SU.FOL.OM3) randomized trial","volume":"172","author":"Andreeva","year":"2012","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ijcard.2012.01.060","article-title":"Cardiovascular effects of B-vitamins and\/or N-3 fatty acids: the Su.Fol.OM3 trial","volume":"167","author":"Blacher","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0033|cit33","first-page":"207","article-title":"The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and\/or omega 3 fatty acid supplements in the prevention of recurrent ischemic events","volume":"21","author":"Galan","year":"2009","journal-title":"Sang Thrombose Vaisseaux"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1745-6215-9-35","article-title":"The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and\/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics","volume":"9","author":"Galan","year":"2008","journal-title":"Trials"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub5-BIB0035|cit35","first-page":"428","article-title":"Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and\/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries","volume":"7","author":"Galan","year":"2003","journal-title":"Journal of Nutrition, Health & Aging"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.c6273","article-title":"Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial","volume":"341","author":"Galan","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"c6273","DOI":"10.1136\/bmj.c6273","article-title":"Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial","volume":"341","author":"Galan","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1017\/S0007114511003692","article-title":"Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD","volume":"107","author":"Szabo de Edelenyi","year":"2012","journal-title":"British Journal of Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/HJR.0b013e3283383f47","article-title":"Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter?","volume":"17","author":"Vesin","year":"2010","journal-title":"European Journal of Cardiovascular Prevention and Rehabilitation"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD006612.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1161\/STROKEAHA.112.665703","article-title":"B vitamins and magnetic resonance imaging-detected ischemic brain lesions in patients with recent transient ischemic attack or stroke: the VITAmins TO Prevent Stroke (VITATOPS) MRI-substudy","volume":"43","author":"Cavalieri","year":"2012","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.STR.0000150494.91762.70","article-title":"Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial","volume":"36","author":"Dusitanond","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0043|cit43","unstructured":"Group Vitatops Study The VITATOPS (VITAmins TO Prevent Stroke) trial: rationale, design and progress of an international, large simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient attack or stroke [Abstract] Internal Medicine Journal 2007 A110"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1161\/STROKEAHA.111.641613","article-title":"Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial","volume":"43","author":"Hankey","year":"2012","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0045|cit45","unstructured":"Hankey GJ The vitamins to prevent stroke (VITATOPS) trial: results of a double-blind, placebo-controlled, randomised trial of B-vitamin therapy in 8,164 patients with recent transient ischaemic attack or stroke Cerebrovascular Diseases 2010 11 10.1159\/000321266"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2261-8-24","article-title":"The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis","volume":"8","author":"Potter","year":"2008","journal-title":"BMC Cardiovascular Disorders"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000199463","article-title":"Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial","volume":"27","author":"Potter","year":"2009","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/STROKEAHA.110.608356","article-title":"The role of vitamin B in stroke prevention: a journey from observational studies to clinical trials and critique of the VITAmins TO Prevent Stroke (VITATOPS)","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD006612.pub5-BIB0049|cit49","first-page":"855-65","article-title":"B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial:a randomised, double-blind, parallel, placebo-controlled trial","volume":"9","author":"The VITATOPS Trial Study Group","year":"2010","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1747-4949.2007.00111.x","article-title":"VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444)","volume":"2","author":"Hankey","year":"2007","journal-title":"International Journal of Stroke"},{"issue":"17","key":"10.1002\/14651858.CD006612.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0052|cit52","first-page":"S1137","article-title":"Effect of folic acid and B vitamins on the occurrence of venous thromboembolism: a randomized trial in women at high cardiovascular risk","volume":"118","author":"Glynn","year":"2008","journal-title":"Circulation"},{"issue":"7","key":"10.1002\/14651858.CD006612.pub5-BIB0053|cit53","first-page":"52","article-title":"A randomized trial of folic acid and B-vitamins in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)","volume":"16","author":"Redbeg","year":"2006","journal-title":"ACC Cardiosource Review Journal"},{"issue":"8","key":"10.1002\/14651858.CD006612.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2337\/db09-0087","article-title":"Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial","volume":"58","author":"Song","year":"2009","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0055|cit55","doi-asserted-by":"crossref","unstructured":"Song Y Cook NR Albert CM Van Denburgh M Manson JE Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes mellitus in women: a randomized controlled trial Circulation 2009 E273","DOI":"10.2337\/db09-0087"},{"issue":"17","key":"10.1002\/14651858.CD006612.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1001\/jama.2008.555","article-title":"Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial","volume":"300","author":"Zhang","year":"2008","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MCA.0b013e328344fff4","article-title":"Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12","volume":"22","author":"Strand","year":"2011","journal-title":"Coronary Artery Disease"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.numecd.2015.12.009","article-title":"B vitamin treatments modify the risk of myocardial infarction associated with a MTHFD1 polymorphism in patients with stable angina pectoris","volume":"26","author":"Ding","year":"2016","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2796.2010.02259.x","article-title":"Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials","volume":"268","author":"Ebbing","year":"2010","journal-title":"Journal of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD006612.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.amjcard.2010.01.019","article-title":"Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy","volume":"105","author":"Loland","year":"2010","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/cen.12451","article-title":"The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial","volume":"81","author":"Bahmani","year":"2014","journal-title":"Clinical Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3945\/jn.114.204743","article-title":"Multivitamin-mineral use is associated with reduced risk of cardiovascular disease mortality among women in the United States","volume":"145","author":"Bailey","year":"2015","journal-title":"Journal of Nutrition"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"579","DOI":"10.5604\/17322693.1102340","article-title":"[Hyperhomocysteinemia in patients with cardiovascular disease]","volume":"68","author":"Baszczuk","year":"2014","journal-title":"Postepy Higieny i Medycyny Doswiadczalnej"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5604\/17322693.1148336","article-title":"Impact of administration of folic acid on selected indicators of inflammation in patients with primary arterial hypertension","volume":"69","author":"Baszczuk","year":"2015","journal-title":"Postepy Higieny i Medycyny Doswiadczalnej"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","article-title":"Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"296","author":"Bazzano","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0067|cit67","unstructured":"Bobak M Pajak A Tamosiunas A Kubinova R Gardiner J Jansen E Plasma concentrations of folate and vitamin B12 and risk of fatal and non-fatal cardiovascular disease: A nested case-control study nested in a population-based cohort European Society of Cardiology annual meeting (http:\/\/congress365.escardio.org\/Search-Results?vgnextkeyword=C365PRESENTATION101078#.VsOczh0X3IU) 2014 4170"},{"issue":"18","key":"10.1002\/14651858.CD006612.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archinternmed.2010.348","article-title":"Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals","volume":"170","author":"Clarke","year":"2010","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/STROKEAHA.110.578906","article-title":"Dietary folate and vitamin b6 and B12 intake in relation to mortality from cardiovascular diseases: Japan Collaborative Cohort Study","volume":"41","author":"Cui","year":"2010","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/1755-5922.12064","article-title":"The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease","volume":"32","author":"Debreceni","year":"2014","journal-title":"Cardiovascular Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3892\/mmr.2013.1563","article-title":"Effect of multivitamins on plasma homocysteine in patients with the 5,10 methylenetetrahydrofolate reductase C677T homozygous state","volume":"8","author":"Dell'edera","year":"2013","journal-title":"Molecular Medicine Reports"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ejcn.2010.15","article-title":"Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India","volume":"64","author":"Deshmukh","year":"2010","journal-title":"European Journal of Clinical Nutrition"},{"issue":"9","key":"10.1002\/14651858.CD006612.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"e0137533","DOI":"10.1371\/journal.pone.0137533","article-title":"Efficacy of supplementation with B vitamins for stroke prevention: A network meta-analysis of randomized controlled trials","volume":"10","author":"Dong","year":"2015","journal-title":"PLOS One"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3945\/ajcn.110.006429","article-title":"Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults","volume":"93","author":"Durga","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1024\/0300-9831\/a000093","article-title":"Complementary effects of multivitamin and omega-3 fatty acid supplementation on indices of cardiovascular health in individuals with elevated homocysteine","volume":"82","author":"Earnest","year":"2012","journal-title":"International Journal for Vitamin and Nutrition Research"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0076|cit76","first-page":"184","article-title":"Combined results and long-term follow-up in NORVIT and WENBIT with 6837 coronary artery disease patients: homocysteine-lowering B-vitamin treatment does not prevent major cardiovascular events","volume":"30","author":"Ebbing","year":"2009","journal-title":"Journal of Internal Medicine"},{"issue":"19","key":"10.1002\/14651858.CD006612.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1001\/jama.2009.1622","article-title":"Cancer incidence and mortality after treatment with folic acid and vitamin B12","volume":"302","author":"Ebbing","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0078|cit78","unstructured":"Nevado J Folate intervention in non-ST elevation myocardial infarction and unstable angina: a randomised placebo-controlled trial http:\/\/controlled-trials.com\/ISRCTN30249553\/homocysteine (accessed 12 October 2007)"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0079|cit79","doi-asserted-by":"crossref","unstructured":"Goel S Messerli FH Efficacy of folic acid in primary prevention of stroke among patients with hypertension in China Journal of the American Society of Hypertension 2015 9 9 665 7 26369441","DOI":"10.1016\/j.jash.2015.08.007"},{"issue":"11","key":"10.1002\/14651858.CD006612.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1017\/S0007114509993552","article-title":"Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations","volume":"103","author":"Green","year":"2010","journal-title":"British Journal of Nutrition"},{"issue":"9791","key":"10.1002\/14651858.CD006612.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(11)60872-6","article-title":"Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials","volume":"378","author":"Holmes","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clnu.2011.01.003","article-title":"Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality","volume":"31","author":"Huang","year":"2012","journal-title":"Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.clnu.2013.01.002","article-title":"Reply to Fang SK--Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality","volume":"32","author":"Huang","year":"2013","journal-title":"Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clnu.2013.01.001","article-title":"Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality","volume":"32","author":"Zhou","year":"2013","journal-title":"Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub5-BIB0085|cit85","first-page":"403","article-title":"Effect of vitamin B-12 and n-3 polyunsaturated fatty acids on plasma homocysteine, ferritin, C-reaction protein, and other cardiovascular risk factors: a randomized controlled trial","volume":"24","author":"Huang","year":"2015","journal-title":"Asia Pacific Journal of Clinical Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1742-1241.2012.02929.x","article-title":"Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis","volume":"66","author":"Huo","year":"2012","journal-title":"International Journal of Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0218492309102494","article-title":"Folic acid-based intervention in non-ST elevation acute coronary syndromes","volume":"17","author":"Imasa","year":"2009","journal-title":"Asian Cardiovascular & Thoracic Annals"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"e3533","DOI":"10.1136\/bmj.e3533","article-title":"The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis","volume":"344","author":"Jardine","year":"2012","journal-title":"BMJ"},{"issue":"15","key":"10.1002\/14651858.CD006612.pub5-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1212\/WNL.0b013e3182a823cc","article-title":"Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis","volume":"81","author":"Ji","year":"2013","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa032845","article-title":"Folate therapy and in-stent restenosis after coronary stenting","volume":"350","author":"Lange","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub5-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/STROKEAHA.109.573410","article-title":"Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: a meta-analysis","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0092|cit92","doi-asserted-by":"crossref","unstructured":"Lee M Hong KS Chang SC Saver JL Efficacy of homocysteine lowering therapy with folic acid in stroke prevention: a meta-analysis of randomized controlled trials Stroke 2010 e291","DOI":"10.1161\/STROKEAHA.109.573410"},{"issue":"8","key":"10.1002\/14651858.CD006612.pub5-BIB0093|cit93","first-page":"1923","article-title":"The association between B vitamins supplementation and adverse cardiovascular events: a meta-analysis","volume":"7","author":"Li","year":"2014","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub5-BIB0094|cit94","first-page":"554","article-title":"[Meta-analysis of clinical trials of folic acid, vitamin B12 and B6 supplementation on plasma homocysteine level and risk of cardiovascular disease]","volume":"43","author":"Li","year":"2015","journal-title":"Zhonghua Xin Xue guan Bing Za Zhi"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2014.03.032","article-title":"The effect of homocysteine-lowering therapy with folic acid on flow-mediated vasodilation in patients with coronary artery disease: a meta-analysis of randomized controlled trials","volume":"235","author":"Liu","year":"2014","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0096|cit96","first-page":"481","article-title":"Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?","volume":"14","author":"Lonn","year":"2007","journal-title":"Current Opinion in Hematology"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.amjcard.2009.05.011","article-title":"Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease","volume":"104","author":"Mager","year":"2009","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"467","DOI":"10.18388\/abp.2010_2432","article-title":"Homocysteine and vitamin therapy in stroke prevention and treatment: a review","volume":"57","author":"Manolescu","year":"2010","journal-title":"Acta Biochimica Polonica"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0099|cit99","first-page":"e140","article-title":"Effect of homocysteine interventions on risk of cardiocerebrovascular events: a meta-analysis of randomized controlled trials","volume":"122","author":"Mei","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1742-1241.2009.02207.x","article-title":"Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials","volume":"64","author":"Mei","year":"2010","journal-title":"International Journal of Clinical Practice"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0101|cit101","first-page":"235","article-title":"Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?","volume":"50","author":"M\u00e9ndez-Gonz\u00e1lez","year":"2010","journal-title":"Revista de Neurologia"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjcard.2010.03.064","article-title":"Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels","volume":"106","author":"Juraschek","year":"2010","journal-title":"American Journal of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD006612.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"A404","DOI":"10.1016\/j.jval.2015.09.942","article-title":"Pharmacoeconomic analysis of the combined homocysteine-lowering and standard therapy versus standard therapy of patients with CHD, postpercutaneous coronary intervention (Pci) and B12 deficiency","volume":"18","author":"Mishchenko","year":"2015","journal-title":"Value in Health"},{"issue":"9","key":"10.1002\/14651858.CD006612.pub5-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1179\/016164110X12644252260475","article-title":"Homocysteine, vitamin B12 and folate levels in Iranian patients with ischemic stroke","volume":"32","author":"Moghaddasi","year":"2010","journal-title":"Neurological Research"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006612.pub5-BIB0105|cit105","first-page":"S171","article-title":"Homocysteine, vitamin B12 and folic acid levels in cerebrovascular accident: a case-control study","volume":"256","author":"Moghaddasi","year":"2009","journal-title":"Journal of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD006612.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.acvd.2009.07.002","article-title":"The controversial role of B-vitamins in cardiovascular risk: an update","volume":"102","author":"Ntaios","year":"2009","journal-title":"Archives of Cardiovascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2009.01.023","article-title":"The effect of folic acid supplementation on carotid intima-media thickness in patients with cardiovascular risk: a randomized, placebo-controlled trial","volume":"143","author":"Ntaios","year":"2010","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1053\/euhj.2002.3161","article-title":"Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease","volume":"23","author":"Neal","year":"2002","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub5-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1017\/S0007114511007033","article-title":"Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials","volume":"108","author":"Pan","year":"2012","journal-title":"British Journal of Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1747493015616512","article-title":"Effect of B-vitamins on stroke risk among individuals with vascular disease who are not on antiplatelets: A meta-analysis","volume":"11","author":"Park","year":"2016","journal-title":"International Journal of Stroke"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.clnu.2014.01.006","article-title":"Folic acid supplementation with and without vitamin B6 and revascularization risk: a meta-analysis of randomized controlled trials","volume":"33","author":"Qin","year":"2014","journal-title":"Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3945\/ajcn.2010.29371","article-title":"Multivitamin use and the risk of myocardial infarction: a population-based cohort of Swedish women","volume":"92","author":"Rautiainen","year":"2010","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0113|cit113","first-page":"13","article-title":"The effects of high-dose folic acid on blood pressure of hypertensive adults with hyperhomocysteinemia: a randomized double-blind placebo controlled clinical trial (Tehran homocysteine survey)","volume":"9","author":"Sharifi","year":"2010","journal-title":"Iranian Journal of Diabetes and Lipid Disorders"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.arcmed.2009.06.004","article-title":"Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial","volume":"40","author":"Shidfar","year":"2009","journal-title":"Archives of Medical Research"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.diabres.2012.05.027","article-title":"Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"98","author":"Sudchada","year":"2012","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3945\/ajcn.2010.29427","article-title":"A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy","volume":"93","author":"Tighe","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0118|cit118","first-page":"50","article-title":"Efficacy of folic acid in prevention of cerebrovascular disease","volume":"1","author":"Vesin","year":"2007","journal-title":"Medecinedes Maladies Metaboliques"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD006612.pub5-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.numecd.2011.04.011","article-title":"Folate and risk of coronary heart disease: a meta-analysis of prospective studies","volume":"22","author":"Wang","year":"2012","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub5-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00394-014-0729-5","article-title":"Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly","volume":"54","author":"Wang","year":"2015","journal-title":"European Journal of Nutrition"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0122|cit122","doi-asserted-by":"crossref","unstructured":"Wang LP Cui WW Nan GX Yu Y Meta-analysis reveals protective effects of vitamin B on stroke patients Translational Neuroscience 2015 6 1 150 6","DOI":"10.1515\/tnsci-2015-0014"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3132\/dvdr.2007.033","article-title":"Homocysteine and cardiovascular disease: a review of the evidence","volume":"4","author":"Wierzbicki","year":"2007","journal-title":"Diabetes & Vascular Disease Research"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0124|cit124","doi-asserted-by":"crossref","unstructured":"Wise J Folic acid significantly reduces risk of first stroke, large Chinese study finds BMJ 2015 350 h1461 25778787","DOI":"10.1136\/bmj.h1461"},{"issue":"8","key":"10.1002\/14651858.CD006612.pub5-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ejim.2012.07.004","article-title":"Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials","volume":"23","author":"Yang","year":"2012","journal-title":"European Journal of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3892\/etm.2014.1553","article-title":"Efficacy of folic acid supplementation on endothelial function and plasma homocysteine concentration in coronary artery disease: A meta-analysis of randomized controlled trials","volume":"7","author":"Yi","year":"2014","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3390\/nu5051531","article-title":"Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia","volume":"5","author":"Zappacosta","year":"2013","journal-title":"Nutrients"},{"issue":"8","key":"10.1002\/14651858.CD006612.pub5-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1017\/S1368980014002134","article-title":"The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis","volume":"18","author":"Zeng","year":"2015","journal-title":"Public Health Nutrition"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0129|cit129","first-page":"55","article-title":"Effect of B vitamins supplementation on cardiovascular and cerebrovascular disease by lowering plasma homocysteine concentration: a meta-analysis [Chinese]","volume":"1","author":"Zhang","year":"2009","journal-title":"Chinese Journal of Evidence-Based Medicine"},{"issue":"11","key":"10.1002\/14651858.CD006612.pub5-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"e81577","DOI":"10.1371\/journal.pone.0081577","article-title":"Effect of B-vitamin supplementation on stroke: a meta-analysis of randomized controlled trials","volume":"8","author":"Zhang","year":"2013","journal-title":"PLOS One"},{"issue":"9","key":"10.1002\/14651858.CD006612.pub5-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"e107060","DOI":"10.1371\/journal.pone.0107060","article-title":"Association between B vitamins supplementation and risk of cardiovascular outcomes: a cumulative meta-analysis of randomized controlled trials","volume":"9","author":"Zhang","year":"2014","journal-title":"PLOS One"},{"issue":"9","key":"10.1002\/14651858.CD006612.pub5-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"e25142","DOI":"10.1371\/journal.pone.0025142","article-title":"Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis","volume":"6","author":"Zhou","year":"2011","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0133|cit133","unstructured":"Efficacy of amlodipine-folic acid tablets on reduction of blood pressure and plasma homocysteine"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0167-5273(15)31026-3","article-title":"Global burden of CVD: focus on secondary prevention of cardiovascular disease","volume":"201 Suppl 1","author":"Bansilal","year":"2015","journal-title":"International Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.arcmed.2015.06.006","article-title":"Global overview of the epidemiology of atherosclerotic cardiovascular disease","volume":"46","author":"Barquera","year":"2015","journal-title":"Archives of Medical Research"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.gheart.2016.10.024","article-title":"The Global burden of disease study and the preventable burden of NCD","volume":"11","author":"Benziger","year":"2016","journal-title":"Global Heart"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub5-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ahj.2007.06.034","article-title":"Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors","volume":"154","author":"Bowman","year":"2007","journal-title":"American Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD006612.pub5-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive--trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"9038","key":"10.1002\/14651858.CD006612.pub5-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(05)70152-5","article-title":"Homocysteine and stroke: evidence on a causal link from mendelian randomisation","volume":"365","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MCO.0b013e328011aa71","article-title":"Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia","volume":"10","author":"Clarke","year":"2007","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub5-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/nu3030370","article-title":"Folic acid food fortification-its history, effect, concerns, and future directions","volume":"3","author":"Crider","year":"2011","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0144|cit144","unstructured":"TSA - Trial Sequential Analysis Copenhagen Trial Unit http:\/\/ctu.dk\/tsa\/"},{"issue":"11","key":"10.1002\/14651858.CD006612.pub5-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.5603\/KP.2015.0229","article-title":"Homocysteine--is it still an important risk factor for cardiovascular disease?","volume":"73","author":"Cybulska","year":"2015","journal-title":"Kardiologia Polska"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00043798-199808000-00004","article-title":"Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies","volume":"5","author":"Danesh","year":"1998","journal-title":"Journal of Cardiovascular Risk"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0147|cit147","volume-title":"Understanding Psychology as a Science: An Introduction to Scientific and Statistical Inference","author":"Dienes","year":"2008"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3389\/fpsyg.2014.00781","article-title":"Using Bayes to get the most out of non-significant results","volume":"5","author":"Dienes","year":"2014","journal-title":"Frontiers in Psychology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0149|cit149","article-title":"Four reasons to prefer Bayesian analyses over significance testing","volume":"Mar 28","author":"Dienes","year":"2017","journal-title":"Psychonomic Bulletin and Review"},{"issue":"11","key":"10.1002\/14651858.CD006612.pub5-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.bbapap.2010.12.006","article-title":"Vitamin B(6) salvage enzymes: mechanism, structure and regulation","volume":"1814","author":"di Salvo","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0151|cit151","first-page":"897","article-title":"Biomedical aspects of pyridoxal 5'-phosphate availability","volume":"4","author":"di Salvo","year":"2012","journal-title":"Frontiers in Bioscience"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","article-title":"Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence","volume":"131","author":"Eikelboom","year":"1999","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-94-007-2199-9_18","article-title":"Physiological and molecular aspects of cobalamin transport","volume":"56","author":"Fedosov","year":"2012","journal-title":"Sub-cellular Biochemistry"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ije\/31.1.59","article-title":"Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies","volume":"31","author":"Ford","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-94-007-2199-9_14","article-title":"Vitamin B6 and cardiovascular disease","volume":"56","author":"Friso","year":"2012","journal-title":"Sub-cellular Biochemistry"},{"issue":"25","key":"10.1002\/14651858.CD006612.pub5-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.jacc.2015.11.011","article-title":"Unraveling the complexities of statistical presentation: Why it is important","volume":"66","author":"Fuster","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-14-6","article-title":"Role of homocysteine in the development of cardiovascular disease","volume":"14","author":"Ganguly","year":"2015","journal-title":"Nutrition Journal"},{"issue":"25 Pt B","key":"10.1002\/14651858.CD006612.pub5-BIB0158|cit158","first-page":"2935","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Lloyd-Jones","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD006612.pub5-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.7326\/0003-4819-130-12-199906150-00019","article-title":"Toward evidence-based medical statistics. 2: The Bayes factor","volume":"130","author":"Goodman","year":"1999","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1191\/1740774505cn098oa","article-title":"Introduction to Bayesian methods I: measuring the strength of evidence","volume":"2","author":"Goodman","year":"2005","journal-title":"Clinical Trials"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1515\/CCLM.2007.347","article-title":"Association between homocysteine, vitamin B(6) concentrations and inflammation","volume":"45","author":"Gori","year":"2007","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0162|cit162","unstructured":"The GRADE Working Group GRADEpro Brozek J Oxman A Sch\u00fcnemann H 2008"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11883-006-0046-4","article-title":"Homocysteine: role and implications in atherosclerosis","volume":"8","author":"Guthikonda","year":"2006","journal-title":"Current Atherosclerosis Reports"},{"issue":"7650","key":"10.1002\/14651858.CD006612.pub5-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0166|cit166","doi-asserted-by":"crossref","unstructured":"Guyatt GH Oxman AD Santesso N Helfand M Vist G Kunz R GRADE guidelines 12. Preparing summary of findings tables-binary outcomes Journal of Clinical Epidemiology 2013 66 2 158 72 22609141","DOI":"10.1016\/j.jclinepi.2012.01.012"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0167|cit167","article-title":"Homocysteine and disease: Causal associations or epiphenomenons?","volume":"Nov 19","author":"Hannibal","year":"2016","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-94-007-2199-9_16","article-title":"Cobalamin deficiency","volume":"56","author":"Herrmann","year":"2012","journal-title":"Sub-cellular Biochemistry"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0170|cit170","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcn\/82.4.806","article-title":"Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials","volume":"82","author":"Homocysteine Lowering Trialists' Collaboration","year":"2005","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0173|cit173","volume-title":"Code of Federal Regulations & International Conference on Harmonisation Guidelines","author":"International Committee on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use","year":"1997"},{"issue":"3-4","key":"10.1002\/14651858.CD006612.pub5-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"Meta-research: the art of getting it wrong","volume":"10","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1515\/CCLM.2005.188","article-title":"Molecular targeting by homocysteine: a mechanism for vascular pathogenesis","volume":"43","author":"Jacobsen","year":"2005","journal-title":"Clinical Chemistry & Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"10","key":"10.1002\/14651858.CD006612.pub5-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD006612.pub5-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.3390\/nu5083235","article-title":"Methoxistasis: integrating the roles of homocysteine and folic acid in cardiovascular pathobiology","volume":"5","author":"Joseph","year":"2013","journal-title":"Nutrients"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijcard.2010.10.005","article-title":"Homocysteine as a new risk factor for cardiovascular events in heart failure","volume":"146","author":"Kardesoglu","year":"2011","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-94-007-2199-9_17","article-title":"Biochemistry of B12-cofactors in human metabolism","volume":"56","author":"Kr\u00e4utler","year":"2012","journal-title":"Sub-cellular Biochemistry"},{"issue":"24","key":"10.1002\/14651858.CD006612.pub5-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1161\/CIRCULATIONAHA.116.008731","article-title":"Endemic cardiovascular diseases of the poorest billion","volume":"133","author":"Kwan","year":"2016","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0182|cit182","doi-asserted-by":"crossref","unstructured":"Lackland DT Weber MA Global burden of cardiovascular disease and stroke: hypertension at the core Canadian Journal of Cardiology 2015 31 5 569 71 25795106","DOI":"10.1016\/j.cjca.2015.01.009"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000437098","article-title":"Homocysteine-induced endothelial dysfunction","volume":"67","author":"Lai","year":"2015","journal-title":"Annals of Nutrition & Metabolism"},{"issue":"26","key":"10.1002\/14651858.CD006612.pub5-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","article-title":"An assessment of clinically useful measures of the consequences of treatment","volume":"318","author":"Laupacis","year":"1988","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0185|cit185","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies In: Higgins JPT, Green S(editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"8","key":"10.1002\/14651858.CD006612.pub5-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2016.06.011","article-title":"Potential impact of time trend of life-style factors on cardiovascular disease burden in China","volume":"68","author":"Li","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12883-015-0311-7","article-title":"Disease burden of stroke in rural South Africa: an estimate of incidence, mortality and disability adjusted life years","volume":"15","author":"Maredza","year":"2015","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cll.2006.06.008","article-title":"Homocysteine","volume":"26","author":"Maron","year":"2006","journal-title":"Clinics in Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.med.60.041807.123308","article-title":"The treatment of hyperhomocysteinemia","volume":"60","author":"Maron","year":"2009","journal-title":"Annual Review of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/17512433.2015.1010516","article-title":"Homocysteine and the pathogenesis of atherosclerosis","volume":"8","author":"McCully","year":"2015","journal-title":"Expert Review of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/cphy.c150021","article-title":"Homocysteine metabolism, atherosclerosis, and diseases of aging","volume":"6","author":"McCully","year":"2015","journal-title":"Comprehensive Physiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-94-007-2199-9_7","article-title":"Genetic aspects of folate metabolism","volume":"56","author":"Molloy","year":"2012","journal-title":"Sub-cellular Biochemistry"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.ATV.20.7.1704","article-title":"Homocysteine and its disulfide derivatives: a suggested consensus terminology","volume":"20","author":"Mudd","year":"2000","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"11","key":"10.1002\/14651858.CD006612.pub5-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.bbapap.2011.06.018","article-title":"Pyridoxal phosphate: biosynthesis and catabolism","volume":"1814","author":"Mukherjee","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/nu3040475","article-title":"Human folate bioavailability","volume":"3","author":"Ohrvik","year":"2011","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fcvm.2015.00032","article-title":"Cardiovascular disease burden: evolving knowledge of risk factors in myocardial infarction and stroke through population-based research and perspectives in global prevention","volume":"2","author":"Oliveira","year":"2015","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"13","key":"10.1002\/14651858.CD006612.pub5-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)","volume":"33","author":"Perk","year":"2012","journal-title":"European Heart Journal"},{"issue":"10","key":"10.1002\/14651858.CD006612.pub5-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"16","key":"10.1002\/14651858.CD006612.pub5-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.114.008729","article-title":"Cardiovascular diseases in India: current epidemiology and future directions","volume":"133","author":"Prabhakaran","year":"2016","journal-title":"Circulation"},{"issue":"32","key":"10.1002\/14651858.CD006612.pub5-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.2174\/0929867321666140706142335","article-title":"Endothelial dysfunction: the link between homocysteine and hydrogen sulfide","volume":"21","author":"Pushpakumar","year":"2014","journal-title":"Current Medicinal Chemistry"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","article-title":"Homocysteine and cardiovascular disease","volume":"49","author":"Refsum","year":"1998","journal-title":"Annual Review of Medicine"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0202|cit202","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006612.pub5-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ndt\/gfw219","article-title":"When is a meta-analysis conclusive? A guide to Trial Sequential Analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery","volume":"32","author":"Roshanov","year":"2017","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"14","key":"10.1002\/14651858.CD006612.pub5-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa1406656","article-title":"Demographic and epidemiologic drivers of global cardiovascular mortality","volume":"372","author":"Roth","year":"2015","journal-title":"New England journal of Medicine"},{"issue":"13","key":"10.1002\/14651858.CD006612.pub5-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.115.016021","article-title":"Estimates of global and regional premature cardiovascular mortality in 2025","volume":"132","author":"Roth","year":"2015","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determinants of homocysteinemia in an elderly population","volume":"270","author":"Selhub","year":"1993","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/15648265080292S116","article-title":"Public health significance of elevated homocysteine","volume":"29 Suppl 2","author":"Shelhub","year":"2008","journal-title":"Food and Nutrition Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub5-BIB0208|cit208","first-page":"106","article-title":"Widening socioeconomic and racial disparities in cardiovascular disease mortality in the United States, 1969-2013","volume":"3","author":"Singh","year":"2015","journal-title":"International Journal of MCH and AIDS"},{"issue":"10","key":"10.1002\/14651858.CD006612.pub5-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"E1733","DOI":"10.3390\/ijms17101733","article-title":"The molecular and cellular effect of homocysteine metabolism imbalance on human health","volume":"17","author":"Skovierova","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.gheart.2012.08.002","article-title":"Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke)","volume":"7","author":"Collins","year":"2012","journal-title":"Global Heart"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2007.09.009","article-title":"Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels","volume":"198","author":"Sofi","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ahj.2004.02.004","article-title":"Homocysteine and cardiovascular disease: biological mechanism, observational epidemiology, and the need for randomised trials","volume":"148","author":"Splaver","year":"2004","journal-title":"American Heart Journal"},{"issue":"8934","key":"10.1002\/14651858.CD006612.pub5-BIB0213|cit213","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD006612.pub5-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"Journal of clinical epidemiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0217|cit217","unstructured":"Sterne JAC Egger M Chapter 10: Addressing reporting biases Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). Available from www.cochrane-handbook.org Wiley-Blackwell"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0219|cit219","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0220|cit220","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) http:\/\/ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"issue":"23","key":"10.1002\/14651858.CD006612.pub5-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1161\/CIRCULATIONAHA.115.008718","article-title":"Worldwide exposures to cardiovascular risk factors and associated health effects: current knowledge and data gaps","volume":"133","author":"Tzoulaki","year":"2016","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1542-4758.2007.00171.x","article-title":"Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events","volume":"11","author":"Vianna","year":"2007","journal-title":"Hemodialysis International"},{"issue":"9871","key":"10.1002\/14651858.CD006612.pub5-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0140-6736(12)62001-7","article-title":"Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals","volume":"381","author":"Vollset","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub5-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jclinepi.2013.10.019","article-title":"The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index","volume":"67","author":"Walsh","year":"2014","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ddmec.2005.05.029","article-title":"Mechanisms in homocysteine-induced vascular disease","volume":"2","author":"Wang","year":"2005","journal-title":"Drug Discovery Today: Disease Mechanisms"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial sequential analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/biof.71","article-title":"Homocysteine metabolism and its relation to health and disease","volume":"36","author":"Williams","year":"2010","journal-title":"Bifactors"},{"key":"10.1002\/14651858.CD006612.pub5-BIB0231|cit231","volume-title":"Food and Nutrition Bulletin","volume":"19","author":"Wirakartakusumah","year":"1998"},{"issue":"7","key":"10.1002\/14651858.CD006612.pub5-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00059-013-3761-y","article-title":"Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China","volume":"38","author":"Wu","year":"2013","journal-title":"Herz"},{"issue":"9","key":"10.1002\/14651858.CD006612.pub5-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cjca.2015.06.035","article-title":"A global perspective on cardiovascular disease in vulnerable populations","volume":"31","author":"Yeates","year":"2015","journal-title":"Canadian Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"322S","DOI":"10.3945\/ajcn.111.013300","article-title":"Folate and vitamin B-12 biomarkers in NHANES: history of their measurement and use","volume":"94","author":"Yetley","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub5-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub5-BIB0236|cit236","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006612","article-title":"Homocysteine lowering interventions for preventing cardiovascular events","author":"Mart\u00ed-Carvajal","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub5-BIB0237|cit237","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006612.pub2","article-title":"Homocysteine lowering interventions for preventing cardiovascular events","author":"Mart\u00ed-Carvajal","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0238|cit238","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006612.pub3","article-title":"Homocysteine-lowering interventions for preventing cardiovascular events","author":"Mart\u00ed-Carvajal","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub5-BIB0239|cit239","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006612.pub4","article-title":"Homocysteine-lowering interventions for preventing cardiovascular events","author":"Mart\u00ed-Carvajal","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006612.pub5\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T05:57:47Z","timestamp":1719381467000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006612.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":239,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006612.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]}}}